127 related articles for article (PubMed ID: 6390854)
1. Antithymocyte globulin-induced prolongation of human renal allograft survival in recipients with in vitro steroid-resistant ADCC.
Dumble LJ; Clunie GJ; Macdonald IM; Bowes LG; Kincaid-Smith P
Transplant Proc; 1984 Dec; 16(6):1503-5. PubMed ID: 6390854
[No Abstract] [Full Text] [Related]
2. Enhanced renal allograft survival from azathioprine/steroid modified antibody-dependent cellular cytotoxicity.
Dumble LJ; Macdonald IM; Kincaid-Smith P; Clunie GJ
Proc Eur Dial Transplant Assoc; 1981; 18():475-80. PubMed ID: 7036169
[TBL] [Abstract][Full Text] [Related]
3. Correlation between ADCC resistance to in vitro steroid and renal allograft failure.
Dumble LJ; Macdonald IM; Kincaid-Smith P; Clunie GJ
Transplant Proc; 1981 Sep; 13(3):1569-71. PubMed ID: 7029817
[No Abstract] [Full Text] [Related]
4. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
[No Abstract] [Full Text] [Related]
5. Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A.
O'Donoghue DJ; Johnson RW; Mallick NP; Gokal R; Ballardie FW; Bakran A; Pearson R; Scott P
Transplant Proc; 1989 Feb; 21(1 Pt 2):1736-7. PubMed ID: 2652568
[No Abstract] [Full Text] [Related]
6. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of canine renal allograft survival by using a synthetic progestin in combination with azathioprine and antithymocyte globulin.
Yellin JA; Enein AA; Goldson H; Hong J; Prince B; Sakai A; Kountz SL
Surg Forum; 1977; 28():309-11. PubMed ID: 364721
[No Abstract] [Full Text] [Related]
8. Steroid sensitivity of chronic uraemic and renal transplant patients measured by the antibody dependent cellular cytotoxicity reaction.
Petri I; Csajbók E; Kiss E; Szenohradszky P; Kaiser G; Gál G
Haematologia (Budap); 1985; 18(4):225-32. PubMed ID: 3915294
[TBL] [Abstract][Full Text] [Related]
9. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
[TBL] [Abstract][Full Text] [Related]
10. Prediction of reversibility of renal allograft rejection.
Gailiunas P; Busch G; Person A; Carpenter CB; Garovoy MR
Transplant Proc; 1979 Mar; 11(1):17-9. PubMed ID: 377625
[No Abstract] [Full Text] [Related]
11. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.
Bowes LG; Dumble LJ; Francis DM; Macdonald IM; Clunie GJ; Kincaid-Smith P
Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672
[No Abstract] [Full Text] [Related]
12. Interferon-enhanced antibody-dependent cell-mediated cytotoxicity and prediction of rejection in renal allograft recipients.
Attallah AM; Abdelghaffar H; Fawzy A; Alghraoui F; Alijani MR; Mahmoud LA; Ghoneim LA; Helfrich GB
Transplant Proc; 1987 Feb; 19(1 Pt 2):1589-91. PubMed ID: 2435032
[No Abstract] [Full Text] [Related]
13. Administration of rabbit antithymocyte globulin (thymoglobulin) in ambulatory renal-transplant patients.
Marvin MR; Droogan C; Sawinski D; Cohen DJ; Hardy MA
Transplantation; 2003 Feb; 75(4):488-9. PubMed ID: 12605115
[TBL] [Abstract][Full Text] [Related]
14. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
[TBL] [Abstract][Full Text] [Related]
15. Immunologic correlates of human renal allograft survival.
Etheredge EE; Sicard GA; Anderson CB
Transplant Proc; 1979 Mar; 11(1):354-9. PubMed ID: 377655
[No Abstract] [Full Text] [Related]
16. Prolongation of dog renal allograft survival by allo-antisera to kidney and xenogeneic antilymphoid globulin.
Smith GV
Surg Forum; 1971; 22():235-7. PubMed ID: 4941304
[No Abstract] [Full Text] [Related]
17. Clinical impact of replacing Minnesota antilymphocyte globulin with ATGAM.
Lum CT; Umen AJ; Kasiske B; Goerdt P; Heim-Duthoy KL; Andersen RC; Odland MD; Ney AL; Jacobs DM; Rao KV
Transplantation; 1995 Feb; 59(3):371-6. PubMed ID: 7871567
[TBL] [Abstract][Full Text] [Related]
18. Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation.
Abouna GM; Kumar MS; Stephan R; Prior JE; Lyons P; Bulova SI; al-Abdullah IH
Transplant Proc; 1993 Jun; 25(3):2241-2. PubMed ID: 8516886
[No Abstract] [Full Text] [Related]
19. Low-dose cyclosporine and antithymocyte globulin improve renal allograft survival in highly sensitized patients.
Palmer A; Bewick M; Welsh K; Snowden S; Parsons V; Taube D
Transplant Proc; 1988 Jun; 20(3 Suppl 3):198-200. PubMed ID: 3291241
[No Abstract] [Full Text] [Related]
20. Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Dhanda R; Shah Y; Bardapure M; Bhattacharjya S; Sharma AK
Transplantation; 2009 Aug; 88(3):444. PubMed ID: 19667954
[No Abstract] [Full Text] [Related]
[Next] [New Search]
